At Johnson & Johnson, we encourage employees to bring their whole selves to work. This diversity of thought helps us better understand our customers and yields a vibrant global community that is working together to solve the world’s greatest healthcare challenges.
While we have taken a leadership role in creating this workplace culture, there is always more we can do. This is why we joined more than 300 companies in signing an amicus brief that was filed with the United States Supreme Court yesterday in the call for all states to legally recognize same -sex marriage.
The brief points out that inconsistent state marriage laws in the U.S. make it difficult and more costly for employers to recruit and retain talented employees, as well as administer benefits.
Our Credo speaks to our responsibility to respect the dignity of our employees, and provide equal opportunity for everyone. By signing this brief, we are making an important statement in support of our current practices and policies, and further bringing Our Credo values to life. Most important for us at Johnson & Johnson, this is consistent with how we treat employees who are committed in same-sex relationships, reinforces our desire to help them fulfill their family obligations, and is inherent in our Company policies that prohibit discrimination on the grounds of sexual orientation.
This is not our first involvement in legal actions that support equal rights. In 2013, we filed amicus briefs supporting the repeal of the Defense of Marriage Act (DOMA) and affirmative action in higher education. We also signed a business coalition to support workplace inclusions for lesbian, gay, bisexual and transgender (LGBT) people in the Employee Non-Discrimination Act (ENDA).
We are proud that the Human Rights Campaign (HRC) recognized Johnson & Johnson in 2014 for the ninth consecutive year with a perfect Corporate Equality Index score.
We also enjoy a strong partnership with PFLAG, the largest family organization that provides education and advocacy for the LGBT community in the U.S. and abroad, to create policy and sustainable culture change. Our Chairman and CEO Alex Gorsky accepted the Straight for Equality in the Workplace Award from PFLAG last year on behalf of the Johnson & Johnson Family of Consumer Companies.
Since 2012, we have donated more than half a million dollars to many organizations committed to LGBT education and outreach, including suicide prevention and family health. Our Care with Pride™ initiative aims to prevent bullying and make schools safer for children.
We will continue to advocate for individualism and fairness. And we remind everyone that it’s not what Johnson & Johnson has done for equality and inclusion in the workplace, but what equality and inclusion have done and will continue to do for the people of our great company and the patients and customers we serve.
Peter M. Fasolo is the Worldwide Vice President, Human Resources, responsible for the global talent, recruiting, diversity, compensation, benefits, employee relations and all aspects of the human resources agenda for the Company. Mr. Fasolo is a member of the Executive Committee, Management Compensation Committee, and Chairman of the Pension and Benefits Committee. He joined Johnson & Johnson in 2004 as Worldwide Vice President, Human Resources for Cordis Corporation. He serves on the Board of the Human Resources Policy Association in Washington, D.C., is a member of the Board of Directors for the Families and Work Institute in New York, also serves on the Board of The Crisis Ministry of Mercer County, and is a Trustee of the Robert Wood Johnson Hospital in New Jersey.
Michael H. Ullmann is Vice President, General Counsel of Johnson & Johnson and a member of the Executive Committee. He has responsibility for the Law Department, Global Security, Health Care Compliance & Privacy and Aviation.Mike joined Johnson & Johnson as a mergers and acquisitions attorney in 1989. He has also served on the Management Boards of Johnson & Johnson Consumer Products Company, Inc., Janssen Pharmaceuticals, Inc. (U.S.) and McNeil Pharmaceuticals.